Hepatic expression of toll-like receptors 3, 4, and 9 in primary biliary cirrhosis and chronic hepatitis C - 05/11/12
, Kavitha Gopal , Henry Bodenheimer , Neil D. Theise 
Corresponding author. Tel.: +917 667 5499.Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
| pagine | 7 |
| Iconografia | 4 |
| Video | 0 |
| Altro | 0 |
Summary |
Toll-like receptors (TLRs) may play a role in the inflammatory patterns observed in primary biliary cirrhosis (PBC) and chronic hepatitis C (CHC). We investigated TLR 3, 4 and 9 expression in PBC and CHC using immunohistochemical staining.
Methods |
Patient biopsies of PBC (N=11) and CHC (N=15) were compared to disease free livers (n=7). The extent of TLR staining was assessed separately according to a semi-quantitative scale for hepatocytes, cholangiocytes and portal mononuclear cells (PMC).
Results |
In hepatocytes, TLR4 expression was increased (PBC; P=0.019), as was TLR9 (PBC; P=0.006, CHC; P=0.001). Cholangiocyte expression of TLRs 4 and 3 was reduced in both PBC (TLR4; P<0.0001, TLR3; P=0.006) and CHC (TLR4; P<0.0001, TLR3; P=0.014). Cholangiocyte expression of TLR9 was elevated for both groups and was significant in CHC (P=0.0115). PMCs showed up-regulation of TLR9 in PBC (P=0.022) and CHC (P=0.0001), with almost no expression of TLR 3 or 4.
Conclusions |
In PBC and CHC, hepatocytes showed increased TLR 4 and 9 expression without change in TLR3. Cholangiocytes showed increased TLR9 expression as opposed to down-regulation of TLRs 3 and 4. PMCs in both diseases had significantly increased TLR 9 expression perhaps implicating TLR9 expression in chronic liver inflammation.
Il testo completo di questo articolo è disponibile in PDF.Mappa
Vol 36 - N° 5
P. 448-454 - Ottobre 2012 Ritorno al numero
Articolo precedente
- Liver injury in HIV monoinfected patients: Should we turn a blind eye to it?
- Maud Lemoine, Patrick Ingiliz
- Performances of Elasto-FibroTest®, a combination between FibroTest® and liver stiffness measurements for assessing the stage of liver fibrosis in patients with chronic hepatitis C
- Thierry Poynard, Victor de Ledinghen, Jean-Pierre Zarski, Carol Stanciu, Mona Munteanu, Julien Vergniol, Julie France, Anca Trifan, Gilles Lenaour, Jean-Christophe Vaillant, Vlad Ratziu, Frederic Charlotte, the Fibrosis-TAGS group 1
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?